KR20180086180A - 다가 엔테로바이러스 백신 조성물 및 이와 관련된 용도 - Google Patents

다가 엔테로바이러스 백신 조성물 및 이와 관련된 용도 Download PDF

Info

Publication number
KR20180086180A
KR20180086180A KR1020187001071A KR20187001071A KR20180086180A KR 20180086180 A KR20180086180 A KR 20180086180A KR 1020187001071 A KR1020187001071 A KR 1020187001071A KR 20187001071 A KR20187001071 A KR 20187001071A KR 20180086180 A KR20180086180 A KR 20180086180A
Authority
KR
South Korea
Prior art keywords
hrv
virus
composition
inactivated
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020187001071A
Other languages
English (en)
Korean (ko)
Inventor
마틴 엘. 무어
이수진
민 트랑 응우옌
Original Assignee
에모리 유니버시티
칠드런스 헬스케어 오브 애틀란타, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에모리 유니버시티, 칠드런스 헬스케어 오브 애틀란타, 인크. filed Critical 에모리 유니버시티
Publication of KR20180086180A publication Critical patent/KR20180086180A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020187001071A 2015-06-15 2016-06-15 다가 엔테로바이러스 백신 조성물 및 이와 관련된 용도 Ceased KR20180086180A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562175832P 2015-06-15 2015-06-15
US62/175,832 2015-06-15
PCT/US2016/037658 WO2016205389A1 (en) 2015-06-15 2016-06-15 Multivalent enterovirus vaccine compositions and uses related thereto

Publications (1)

Publication Number Publication Date
KR20180086180A true KR20180086180A (ko) 2018-07-30

Family

ID=57546427

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187001071A Ceased KR20180086180A (ko) 2015-06-15 2016-06-15 다가 엔테로바이러스 백신 조성물 및 이와 관련된 용도

Country Status (7)

Country Link
US (1) US11160857B2 (OSRAM)
EP (1) EP3307311A4 (OSRAM)
JP (2) JP6902195B2 (OSRAM)
KR (1) KR20180086180A (OSRAM)
CN (1) CN108025055B (OSRAM)
CA (1) CA2989332A1 (OSRAM)
WO (1) WO2016205389A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016205389A1 (en) * 2015-06-15 2016-12-22 Emory University Multivalent enterovirus vaccine compositions and uses related thereto
CN109337876A (zh) * 2018-10-15 2019-02-15 北京世纪元亨动物防疫技术有限公司 一种猪流行性腹泻病毒的纯化方法
EP3927372A4 (en) * 2019-02-21 2023-01-25 Centivax, Inc. OPTIMIZED VACCINE COMPOSITIONS AND METHODS OF PRODUCTION
CN115869324B (zh) * 2022-12-30 2024-02-27 湖北工业大学 Efavirenz在制备抗肠道病毒药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946676A (en) 1986-08-27 1990-08-07 De Staat Der Nederlanden Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide
US5714374A (en) 1990-09-12 1998-02-03 Rutgers University Chimeric rhinoviruses
US20020086386A1 (en) 1997-03-04 2002-07-04 Kamb Carl Alexander B-catenin assays, and compositions therefrom
US20060088549A1 (en) 2004-07-08 2006-04-27 Arnold Gail F Chimeric virus vaccine
US8153760B2 (en) 2005-01-19 2012-04-10 Donald Danforth Plant Science Center Rhinovirus vaccines
US8652486B2 (en) * 2006-09-29 2014-02-18 Sanofi Pasteur Biologics, Llc Neutralizing immunogen (NimIV) of rhinovirus and its use for vaccine applications
JP2011517408A (ja) * 2008-03-27 2011-06-09 サノフィ パスツール バイオロジクス カンパニー 組換えライノウイルスベクター
US20120088814A1 (en) * 2009-03-31 2012-04-12 Isis Pharmaceuticals, Inc. Methods of modulating an immune response to a viral infection
CN102905728B (zh) * 2010-05-26 2015-11-25 西莱克塔生物科技公司 具有不偶合的佐剂的纳米载体组合物
EP2765137A1 (en) 2013-02-07 2014-08-13 Sanofi Pasteur Induction of cross-reactive cellular response against rhinovirus antigens
PT3010537T (pt) * 2013-06-17 2019-12-03 De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport Métodos para a prevenção da agregação de componentes virais
JP6774149B2 (ja) * 2014-05-28 2020-10-21 ナショナル ヘルス リサーチ インスティテューツＮａｔｉｏｎａｌ Ｈｅａｌｔｈ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅｓ エンテロウイルス感染に対する免疫原としてのウイルス粒子およびその生産
WO2016205389A1 (en) * 2015-06-15 2016-12-22 Emory University Multivalent enterovirus vaccine compositions and uses related thereto

Also Published As

Publication number Publication date
JP6902195B2 (ja) 2021-07-14
CN108025055A (zh) 2018-05-11
US20180169215A1 (en) 2018-06-21
JP2018517722A (ja) 2018-07-05
US11160857B2 (en) 2021-11-02
JP2021152024A (ja) 2021-09-30
EP3307311A4 (en) 2019-02-13
CN108025055B (zh) 2022-08-26
EP3307311A1 (en) 2018-04-18
WO2016205389A1 (en) 2016-12-22
CA2989332A1 (en) 2016-12-22

Similar Documents

Publication Publication Date Title
ES2535310T3 (es) Atenuación sinérgica del virus de la estomatitis vesicular, vectores del mismo y composiciones inmunogénicas del mismo
AU2020244533B2 (en) Recombinant RSV with silent mutations, vaccines, and methods related thereto
JP5933565B2 (ja) 組み換え改変ワクシニアウイルスアンカラインフルエンザワクチン
JP2021152024A (ja) 多価エンテロウイルス（Ｅｎｔｅｒｏｖｉｒｕｓ）ワクチン組成物およびそれに関連する使用
US20130302367A1 (en) Virus vector for prime/boost vaccines, which comprises vaccinia virus vector and sendai virus vector
JP2006523224A (ja) 免疫原性組成物および方法
KR101723900B1 (ko) 면역화 요법용 발현 벡터로서의 수포성 구내염 바이러스의 상이한 혈청형
US11793844B2 (en) Virus for treatment of tumor
JP2022523157A (ja) キメラ型ＲＳＶおよびｈＭＰＶ Ｆタンパク質、免疫原性組成物、ならびに使用方法
JP2024535145A (ja) 改変ワクシニアウイルスアンカラ（ｍｖａ）による細胞傷害性導入遺伝子発現を下方調節するためのマイクロｒｎａの利用
EP3783100A1 (en) Coxsackie virus b for treating tumors
US20260115277A1 (en) Immunogenic compositions for epstein-barr virus proteins
US12053518B2 (en) Method for rescuing and producing a virus in avian cells
US20220023413A1 (en) Recombinant mumps virus vaccine expressing genotype g fusion and hemagglutinin-neuraminidase proteins
CN1318592C (zh) O型口蹄疫病毒dna疫苗及其制备方法
CN101993498B (zh) 腺病毒载体禽流感重组疫苗
CN119570817B (zh) 多抗原猴痘rna疫苗及其制备方法
EP4574168A1 (en) Prime-boost immunization against influenza
JP5635950B2 (ja) 免疫原性組成物および方法
US20250312441A1 (en) Immunogenic compositions for herpes simplex virus proteins
CA3070628C (en) Enterovirus d68 (ev-d68) for treatment of tumor
CN119432910A (zh) 用于疫苗制备的重组质粒及其制备方法和dna启动的减毒活手足口病疫苗
CN121773126A (zh) 疫苗组合物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20180112

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210608

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240216

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20240711

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D